Aims: Detection/Quantification of RNA viruses is mostly done by reversetranscriptase (RT)-(q)PCR, but it does not distinguish between infectious and noninfectious viruses. Our aim was to test, how different pretreatments before RT-qPCR could eliminate positivity originated from external nucleic acids or genomes of damaged particles. Methods and Results: Heat-inactivated (80°C for 10 min) rotavirus Wa strain and faecal samples containing rotavirus or norovirus were treated with PMA/
Introduction
Human rotavirus (RV) and norovirus (NoV) are the most important viruses causing gastrointestinal illness worldwide. Despite effective vaccines have greatly decreased RV mortality, ≥200 000 children still die annually because of RV infection (Tate and Parashar 2014) ; Tate et al. 2016) . Majority of these deaths occur in the developing countries, where contaminated drinking water is an important source of infection. For NoV, it has been estimated, that annual morbidity was 677 billion in 2010, and it caused >200 000 deaths (Pires et al. 2015) .
Rotavirus has a segmented double-stranded RNA genome that is shielded by an inner core (core protein VP2), an inner capsid (VP6) and an outer capsid (protein VP7 and a spike protein VP4; Azevedo et al. 2013) . NoV is quite different from RV, since it has a nonsegmented, single-stranded RNA genome, and its virion is formed of a major capsid protein VP1 and a minor structural protein VP2 (Tan and Jiang 2014) .
Capsid damage with subsequent damage of the genome appears to be the most common reason for rendering viruses noninfectious (Cliver 2009 ). An undamaged capsid is crucial for viruses for entering the host cell, but it also protects the viral genome, e.g. from nucleases. Another important mechanism for rendering viruses noninfectious is a direct damage to the genome, which can happen, for example, when the virus is subjected to ultraviolet (UV) light.
Infected persons shed immense amounts (up to 10 10 ) of these viruses into faeces, which is further discharged to sewage. Survival of the viruses in surface or ground water depends on the virus in question; rotavirus and norovirus can survive infectious for weeks to months (Bae and Schwab 2007; Espinosa et al. 2008) . Nowadays, the detection of viruses is usually made by (reverse-transcription)-polymerase chain reaction, RT-PCR. The downside of this method is, when compared to cell-culture methods, that it does not provide any information on whether the genome equivalents are associated to infectious viral particles or not. The infectivity of the detected viral particles is, however, important to know when assessing the risk of faecally contaminated water to consumers.
The abilities of different enzymatic pretreatments for removing damaged, noninfectious viral particles from samples containing viruses prior to RT-PCR have been tested widely (Nuanualsuwan and Cliver 2002; Lamhoujeb et al. 2008; Topping et al. 2009; Diez-Valcarce et al. 2011; Li et al. 2012; Escudero-Abarca et al. 2014; R€ onnqvist et al. 2014; Manuel et al. 2017; Monteiro and Santos 2017) . Proteinases have been used to break down partially damaged viral capsids, and RNases to digest free nucleic acids from damaged viral particles. In addition to enzymatic treatments, also chemicals, such as intercalating dyes propidium monoazide (PMA) and ethidium monoazide (EMA), as well as surfactants, have been used to get the same end result. (Parshionikar et al. 2010; Kim and Ko 2012; S anchez et al. 2012; Coudray-Meunier et al. 2013; Elizaquivel et al. 2014; Escudero-Abarca et al. 2014; Karim et al. 2015; Leifels et al. 2015; Monteiro and Santos 2017) . PMA acts by covalently binding to nucleic acids upon photoactivation and prevents amplification, while surfactants may help PMA to penetrate mildly damaged viral capsids (Coudray-Meunier et al. 2013) . Other methods, such as various binding assays and large fragment amplification, have been applied for discriminating intact particles or genomes from the damaged ones (Li et al. 2011; Ceuppens et al. 2014) . Based on the literature, it seems that the effect of a pretreatment is highly dependable on the virus in question, sample matrix and of the process that has been used for viral inactivation, be it heat, chlorination, UV-irradiation, or something else.
The purpose of this study was to evaluate the abilities of PMA, PMAxx (a dye structurally related to PMA, but with different chemical properties), benzonase and RNase pretreatments to reduce the quantified RT-qPCR genome copy (gc) numbers of thermally inactivated RV and NoV. Benzonase is a nuclease that degrades both single-and double-stranded RNA and DNA (Miller et al. 1994) . To our knowledge, it has not been used in this context before. As model viruses, we used cell culture-propagated RV strain Wa, and two faecal samples containing either RV or NoV.
Materials and methods

Preparation of the virus stocks
MA104 cells were grown in Eagle's Minimum Essential Medium (EMEM; Sigma-Aldrich Co., Saint Louis, MO), containing 10% heat-inactivated foetal bovine serum (Thermo Fischer Scientific Inc., Waltham, MA), 10 mmol l À1 HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) solution (Sigma-Aldrich Co.) and 1% glutamine-penicillin-streptomycin (Sigma-Aldrich Co.). The cells were incubated at 37°C in an atmosphere containing 5% CO 2 until they reached 80% confluency. The cells were infected with rotavirus strain Wa G1P [8] (kindly gifted by Professor Lennart Svensson at the Link€ oping University, Link€ oping, Sweden) according to the protocol described by Arnold et al. (2009) . Incubation at 37°C was continued for 2-3 days, and the cells were checked for cytopathic effect. The viruses were released by freeze-thawing and centrifuged at 4500 g for 10 min. The supernatant was divided into aliquots and stored at À70°C. Infectivity of the virus stock was measured by the 50% tissue culture infectious dose method (TCID 50 per ml). In brief, 1Á0 9 10 3 cells were seeded into each well in a 24-well plate, and four parallel wells were infected with 200 ll of each 10-fold serial dilution of trypsin-activated rotavirus Wa. The Wa stock contained approximately 3 9 10 5 TCID 50 per ml À1 .
Also, two 10% human (anonymous) faecal suspensions, one containing a high number of RV G1P[8] particles by electron microscopy (EM; from here on referred as F_RV), and the other containing a high genome load of NoV GI.Pb-GI.6 (from here on referred as F_NoV; GenBank accession no. for ORF1 identical to KT943508 and for ORF2 to KT943509; Oristo et al. 2017) , were prepared in sterile 1 9 phosphate buffered saline (PBS; Sigma-Aldrich Co.). The faecal suspensions were thoroughly mixed by vortexing, and incubated at 6°C for 24-72 h, before clarification by centrifugation at 10 000 g for 10 min. The supernatants were stored in aliquots at À70°C.
To obtain optimal concentrations for the RT-qPCR experiments, the Wa stock and the faecal suspensions F_RV and F_NoV were further diluted in PBS. The working dilutions were freshly prepared for each experiment. The RT-qPCR concentrations of these diluted Wa, F_RV and F_NoV aliquots were determined to be 1Á7 9 10 8 (gc) ml À1 (corresponding to approximately 3 9 10 3 TCID 50 per ml), 7Á6 9 10 8 gc per ml, and 3Á2 9 10 8 gc per ml, respectively, by the RT-qPCR methods described below. The corresponding concentrations in 1 ll of extracted RNA were 2Á8 9 10 5 gc for Wa, 1Á3 9 10 6 for F_RV, and 5Á3 9 10 5 for F_NoV.
Thermal inactivation of the model viruses
To determine the time for complete inactivation of Wa, virus aliquots were thermally treated at 80°C for 1-30 min in a dry bath, and the TCID 50 concentration was determined as described above. In addition, the stage of the heat-inactivated (80°C for 10 min) samples containing F_RV particles was examined by EM. Viruses were identified on grids negatively stained with 1% potassium phosphotungstate, pH 6Á5. For PMA and nuclease treatment studies, we inactivated the viral aliquots in a dry bath set at 80°C for 10 min, after which they were placed on ice immediately. Virus samples without and with heat inactivation are referred as 'infectious' and 'heat-inactivated' viruses, respectively.
PMA/PMAxx pretreatments
Based on our preliminary tests, we decided to use a final concentration of 100 lmol l À1 PMA/PMAxx (Biotium,
was stored in aliquots at À20°C, protected from light. As a first step, we tested the ability of PMA/PMAxx to bind to free nucleic acids by treating 100 ll aliquots of extracted Wa RNA with lmol l À1 of PMA/PMAxx. PMA/PMAxx-treated samples underwent incubation in the dark for 60 min at 6°C, and photoactivation (performed with Biotium-Lite LED Photolysis device (Biotium)) for 15 min at room temperature.
Half of the PMA/PMAxx-treated RNA samples were further purified with the QiaQuick PCR Purification kit (QIAGEN, Hilden, Germany), according the manufacturer's instructions, and half was not purified further. Adequate controls treated with lmol l À1 PMA/PMAxx, and either subjected to photoactivation or not, were included in the experiments. PMA/PMAxx treatment for infectious or heat-inactivated Wa, F_RV and F_NoV samples was done accordingly by adding the dye into 100 ll aliquots of virus. Virus containing samples were frozen (À20°C) until subjected to RNA extraction. All experiments with the infectious and heat-inactivated viruses were done at least thrice. With PMA/PMAxx, we used the 1Á5 ml DNA LoBind Eppendorf tubes (Sigma-Aldrich Co.).
Nuclease pretreatment
We first wanted to ensure that benzonase (Sigma-Aldrich) degrades nucleic acids efficiently. Benzonase treatment was otherwise performed similarly to PMA treatment, but with 100 U of benzonase per sample, and incubation at 37°C for 1 h. Treatment of the 100 ll aliquots of infectious and heat-inactivated Wa, F_RV and F_NoV samples was performed similarly prior to RNA extraction.
Pretreatment of the viral aliquots with a crude mixture of RNases from bovine pancreas (Roche Diagnostics, Mannheim, Germany) was performed as described by R€ onnqvist et al. (2014) , with minor modifications. Briefly, 4 U of RNase was added per 100 ll of diluted Wa, F_RV or F_NoV aliquots, and the mixtures were then incubated for 30 min at 37°C. 80 U of RiboLock RNase inhibitor (Promega, Madison, WI) was added after the incubation to stop the reaction.
The control samples were always treated the same way as the nuclease-treated samples, but without addition of nuclease. We also tested, if the heating of F_NoV samples at 37°C for 30 or 60 min would decrease the viral titre in comparison with the samples kept at 6°C (PMA treatment) for the similar amount of time. All experiments with the infectious and heat-inactivated viruses were done at least thrice, except for the infectious Wa samples treated with benzonase, which was done twice.
RNA extraction and detection of Wa and F_RV by RTqPCR
RNA of the Wa and F_RV samples was extracted with the E.Z.N.A Viral RNA kit (Omega Bio-Tek Inc., Norcross, GA). The extractions were performed according to the manufacturer's instructions, except that the volume of each sample was adjusted to 140 ll with PBS prior to the extraction, and the samples were eluted in 60 ll using the elution buffer provided by the extraction kit's manufacturer. The RNA samples were stored at À20°C until further use.
Expand reverse-transcriptase enzyme (25 U) (Roche Diagnostics GmbH) was used to produce cDNA of RV RNA. The 10 ll-mix was otherwise prepared as described by Kantala et al. (2009) 
Digital droplet PCR and standard curves
Digital droplet PCR (ddPCR) was used for determining the genome copy numbers of the standard samples (Wa and F_NoV). Detection of viruses was performed in 22 ll-volume reactions with the One-Step RT-ddPCR Advanced Kit for Probes (Bio-Rad, Irvine, CA), 1Á0 lmol l À1 of each (virus-specific) forward and reverse primers, 0Á2 lmol l À1 of probe (Table 1 ) and 5 ll of template RNA. Droplets were generated with Automated Droplet Generator (Bio-Rad), and the samples were then subjected to amplification in the following conditions: RT at 50°C for 60 min and initial activation at 95°C for 10 min, followed by 43 cycles of 95°C for 30 s and 60°C for 60 s. Deactivation was done at 98°C for 10 min. Results were analysed using the QX200 TM Droplet Digital TM PCR System (Bio-Rad). Standard curves for the RT-qPCR protocols were prepared from 10-fold serial dilutions of the standard samples. The RT-qPCR titres for the samples were obtained by plotting their C t values against their corresponding standard curves.
Statistical and mathematical analysis
GraphPad software (https://www.graphpad.com/quickcalc s/ttest1/) was used for the statistical pairwise t-test analyses of the results. P-values of <0Á05 were considered statistically significant. When calculating log 10 -reductions, our principle was to compare every inactivated sample with the control (nontreated or treated), that gave the lowest titre. Thus, RV was compared with controls that were not heat-inactivated, but treated with PMA/PMAxx or nucleases. NoV was compared with controls that were heat-inactivated, but not treated with PMA/PMAxx or nucleases.
Results
Thermal inactivation of the model viruses
RV Wa was completely inactivated after heat treatment at 80°C for 5 min, when determined by the TCID 50 method (data not shown). The heat-inactivated (80°C, 10 min) faecal sample F_RV contained only destroyed remnants of viral particles in EM (data not shown). The effect of the thermal inactivation on the RT-qPCR titres of Wa and F_RV (À0Á07, and À0Á26 log 10 reductions, respectively) was negligible. In contrast, the titre of F_NoV decreased significantly, by 2Á35 log 10 gc (P < 0Á05; data not shown). The absolute titres are presented in Table 2 .
Since the genome of F_NoV in our sample seemed to be heat-labile at 80°C, we tested if incubation at 37°C (the temperature used during nuclease treatments), would also alter its titre. However, no statistically different results were obtained between the samples incubated at 37°C and 6C°( the temperature used during PMA treatment) for 30 or 60 min (P > 0Á05; data not shown). Thus, identical pretreatment conditions were applied for RV and NoV.
Effects of PMA/PMAxx treatments on the RT-qPCR titres of infectious and inactivated viruses
Unbound PMA effectively inhibited the detection of free RV Wa nucleic acids by RT-qPCR (P < 0Á05; data not shown). This effect was avoided by purification of the Wa RNA with the QiaQuick PCR Purification kit. Without photoactivation, PMA reduced the titre of the extracted, purified Wa RNA only negligibly (0Á03 log 10 gc; P > 0Á05), but with photoactivation, the reduction was 1Á31 log 10 gc (P < 0Á05; data not shown). Accordingly, when infectious or heat-inactivated RV was treated with PMA or PMAxx, but not subjected to photoactivation, their titres did not differ significantly from the controls (À0Á23 to 0Á09 log 10 gc; P > 0Á05; data not shown).
Unexpectedly, however, PMA treatment with photoactivation reduced the titres of infectious (no thermal treatment) Wa and F_RV by 0Á73 and 1Á65 log 10 gc, respectively (P < 0Á05; Table 2 , Fig. 1a , columns below xaxis). The same applied for PMAxx, with reductions of 1Á63 and 2Á02, respectively (P < 0Á05; Table 2 , Fig. 1b) . So, to verify the efficiency of PMA/PMAxx, we compared the results of the heat-inactivated PMA/PMAxx-treated samples with the infectious, nonheat-inactivated PMA/ PMAxx-treated controls (see the methods section for additional information). The log 10 reductions of the heatinactivated, PMA or PMAxx-treated Wa were modest, 0Á18 and 0Á21 log 10 gc, respectively (P values for both <0Á05; Fig. 1a,b ; columns on or above x-axis). PMA treatment hardly caused any titre reduction for heat-inactivated F_RV (P = 0Á5; Fig. 1a) . However, the performance of PMAxx was better (0Á86 log 10 gc reduction; P < 0Á05; Fig.1b) .
Promisingly, and in contrast to the abovementioned results with infectious RV and PMA/PMAxx, application of PMA or PMAxx into infectious F_NoV did not affect its titre (À0Á05 to 0Á02 log 10 gc; P > 0Á05; Table 2 ), but thermal treatment affected. So, we compared the heatinactivated F_NoV that was PMA/PMAxx-treated with the heat-inactivated non-PMA/PMAxx-treated counterparts (the controls that gave the lowest value). In addition to the F_NoV genome load decrease of 2Á35 log 10 by heat alone, pretreatment with PMA or PMAxx still resulted in further reductions of 0Á79 and 0Á84 log 10 gc, respectively (P values for both <0Á05; Table 2 , Fig. 1a,b) .
Effects of nuclease treatments on the RT-qPCR titres of infectious and inactivated viruses
Treatment of the extracted, nonpurified or purified RV Wa RNA with 100 U of benzonase could render it nondetectable by RT-qPCR (4Á48-4Á72 log 10 gc reduction; data not shown). When applied to the infectious Wa, benzonase pretreatment resulted in an unwanted decrease in the titre (0Á76 log 10 gc; P < 0Á05; Table 2 , Fig. 1c) , but, contrarily, did not decrease the titres of infectious F_RV and F_NoV (0Á15 and 0Á00 log 10 gc, respectively (P > 0Á05; Table 2 , Fig. 1c ). Benzonase pretreatment reduced the titre of heat-inactivated Wa only by 0Á38 log 10 (P > 0Á05), but that of F_RV by 2Á17 log 10 gc (P < 0Á05) -the latter being the second-best value in the study -when compared to their infectious controls treated with benzonase (Fig. 1c) . Benzonase pretreatment of the heat-inactivated F_NoV did not cause any further titre reduction (Fig. 1c) .
The titres of the infectious Wa, F_RV and F_NoV were somewhat reduced by the RNase treatment (0Á88, 0Á51 and 0Á46 log 10 gc, respectively; P values for all <0Á05; Table 2 , Fig. 1d ). RNase worked well for the inactivated samples, since after heat treatment, the titres of Wa and 
*The average log 10 genome copy (gc) titres of controls that were included in the RT-qPCR tests of the pretreated infectious controls.
F_RV were reduced by 1Á66 and 2Á77 log 10 gc (P values for both <0Á05), respectively, in comparison with their infectious controls treated with RNase (Fig. 1d) . RNase treatment of the heat-inactivated F_NoV resulted in a further 0Á80 log 10 -reduction, when compared to the inactivated F_NoV, not treated with RNase (P value <0Á05; Fig. 1d ).
Discussion
In this study, we evaluated the performance of different pretreatments in eliminating false-positive RT-qPCR signals originating from heat-inactivated viruses, since reliable methods are urgently needed, especially for noncultivable viruses (Ceuppens et al. 2014; Fuster et al. 2016) . None of the pretreatments worked perfectly, since they were not able to render the inactivated virus samples negative in RTqPCR. PMA/PMAxx pretreatments seemed to work to some extent for heat-inactivated norovirus. Benzonase pretreatment worked well for F_RV (2Á2 log 10 gc reduction) and moderately for Wa, but not at all for NoV. The most promising of these pretreatments was with crude mixture of RNase that had some effect for both RV and NoV, and that gave the highest titre reduction (almost 3 log 10 for heat-inactivated F_RV) of our study. We observed a difference in the thermal resistance at 80°C between dsRNA genome of RV and ssRNA genome of NoV GI (GI.6). Contrary to RV, a statistically significant (c. 2-log) reduction in the F_NoV gc titre was noticed after heat treatment using RT-qPCR without any pretreatment. This finding is somewhat surprising, since other studies have reported zero to very minor decreases in the NoV genome after heating them at temperatures of 72-95°C for 5-15 min (Li et al. 2012; Escudero-Abarca et al. 2014; Karim et al. 2015; Monteiro and Santos 2017) . One exception is the study of Parshionikar et al. (2010) that shows an 11-fold decrease in Norwalk concentration after treatment at 37°C for 2 weeks by RTqPCR alone. These discrepancies might be partly explained by that the other studies used more concentrated viruses during heating, while we wanted to perform our NoV tests in approximately the same concentration as the tests with RV, which was our primary target virus in this study. Individual qualitative and quantitative contents of faecal suspensions might have an effect as well. PMA treatment prior to RT-qPCR has been shown to be relatively reliable in discriminating infectious viruses from inactivated ones when hepatitis A viruses (S anchez et al. 2012) and polioviruses (Parshionikar et al. 2010; Karim et al. 2015) have been treated. The results of NoV treatments with PMA are, however, controversial. Escudero- Abarca et al. (2014) determined the D value, which indicates the time required to destroy 90% of the microbe population for PMA-treated Snow Mountain virus (SMV; NoV GII) to be only 3Á1 min at 80°C, suggesting good performance of PMA treatment for NoV.
On the other hand, Parshionikar et al. (2010) reported that PMA treatment (100 lmol l À1 ) of heat-inactivated (72°C, about 5 min) NoV (10 3 gc ml À1 ) could render it nondetectable by RT-PCR, although not with RT-qPCR. Karim et al. (2015) also reported the inefficiency of PMA to render NoV negative in RT-qPCR. Our results that were somewhat hampered by degradation of NoV genome during heat inactivation were in line with Karim et al. (2015) , because PMA caused only less than a log 10 reduction for F_NoV. PMAxx was found to function slightly better than PMA, but it was still not able to prevent all false-positive RT-qPCR signals.
In our experiments, PMA and especially PMAxx treatment resulted in the genome titre reduction of the cell-grown Wa sample (0Á73 log 10 and 1Á63 log 10 gc, respectively), and also Coudray-Meunier et al. (2013) reported a reduction of 0Á52 log 10 for RV with PMA. Cell-grown crude rotavirus samples contain always immature, noninfectious particles that have lost their outer capsids as well as viral components together with intact virions, as evidenced by EM (Settembre et al. 2011 ). This could partially explain the reduction, since by PMA/ PMAxx can enter partially damaged virus particles. To our knowledge, it has not been studied, whether the trypsin treatment of RV (that cleaves spike protein VP4 to subunits VP5* and VP8*), which is necessary for virus infectivity in cell culture, affects the accessibility of PMA into RV particles. More studies are needed to sort out these issues. Coudray-Meunier et al. (2013) reported that PMA treatment of the heat-inactivated RV Wa (68 or 80°C, 10 min) caused a 1Á45 log 10 reduction and Leifels et al. (2015) found that the PMA treatment reduced the titre of RV by 1Á19 log 10 (65°C, 10 min). In our hands, PMA/ PMAxx treatment did not much affect the titre of the RV treated at 80°C for 10 min (maximum decrease of 0Á22 log 10 gc). The discrepancies between the results of our and the abovementioned studies may be explained by the differences in the virus preparation, or in the methods used. However, the conclusion in both these studies was that viral targets influence the effectiveness and viruses have different inactivation mechanisms, which statements are in agreement with our results.
To our knowledge, benzonase has not been used as an alternative for RNase before, so we have no reference to our results. Under the same thermal inactivation conditions, nearly similar titre reductions (2Á17 and 2Á77 log 10 gc, respectively) were observed for faecal RV when it was treated with either benzonase or RNase prior to RTqPCR. However, benzonase had little to no effect for the inactivated Wa and F_NoV. It is possible that there was something in the sample matrix of the cell-cultured Wa that hindered the ability of benzonase to degrade free nucleic acids. While NoV results were obscured by the abovementioned tremendous NoV genome degradation by heat alone, more research is clearly needed to reveal the applicability of benzonase pretreatment, when virus is inactivated with different processes (heat, UV, chlorine). However, by adjusting the inactivation conditions, and both benzonase and virus concentrations, this pretreatment may finally prove to be very practical.
In our hands, RNase pretreatment performed well for RV (1Á66-2Á77 log 10 reductions for Wa and F_RV, respectively), when all three pretreatments were compared. To our knowledge, we do not have published studies to compare our results with RNase-treated RV. In a study of Coudray-Meunier et al. (2013) , different pretreatments (PMA/EMA and surfactants) were used to develop a method to differentiate between infectious and inactivated RV particles by RT-qPCR. Given the importance of RV as a cause of waterborne outbreaks, RNase method should be further validated for RV, because it could prove to be very practical in situations, where water or food is suspected to be contaminated by faeces.
RNase pretreatment worked to some extent for NoV, causing a similar log 10 reduction as PMA/PMAxx pretreatments (0Á80 log 10 gc) without affecting infectious, nonheat-inactivated virus. Our NoV results are in line with those of several studies that have assessed the usability of RNase pretreatments to measure survival or persistence of NoV (Topping et al. 2009; Li et al. 2012; Escudero-Abarca et al. 2014; R€ onnqvist et al. 2014; Manuel et al. 2017) . For example, Li et al. (2012) reported a decrease of 1Á15 log 10 gc after heat treatment of NoV GII.4 at 85°C for 2 min using RNAse ONE. RNAse ONE treatment was also successfully used in the study of Escudero-Abarca et al. (2014) that determined the D value for the RNase-treated SMV to be 3Á9 min at 80°C. In contrast, in the study of Monteiro and Santos (2017) , RNase A caused practically no decrease in the titre of heat-inactivated NoV GII.4. The discrepancies between these studies may result from numerous issues, e.g. the use of different NoV genotypes, virus concentrations, thermal treatments, type of RNase and/or sample matrices.
Almost all pre-RT-qPCR treatments seemed to be more effective in differentiating infectious from inactivated RV particles in the faecal sample, than in the cell-culture media. Indeed, it is important that pretreatments would work reliably for viruses in faecal matrix, since sewage of human origin is a common source for NoV and RV contamination, e.g. in surface waters (Lodder and de Roda Husman 2005; Kiulia et al. 2010 ). In conclusion, this study gives us more understanding about the performance of pretreatments in distinguishing infectious RV and NoV. However, numerous data gaps are still to be filled, before the optimal pretreatments for particular viruses in various matrices, and after certain inactivation processes, can be established.
